Neumora Therapeutics (NASDAQ:NMRA) just reported results for the first quarter of 2024.Neumora Therapeutics reported earnings per share of -34 cents. This met the analyst estimate for EPS of -34 cents.The company did not report any revenue for the quarter.InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analys ...